Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Binding Properties of Zearalenone Mycotoxins to Hepatic Estrogen Receptors

W. POWELL-JONES, S. RAEFORD and G. W. LUCIER
Molecular Pharmacology July 1981, 20 (1) 35-42;
W. POWELL-JONES
Laboratory of Organ Function and Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. RAEFORD
Laboratory of Organ Function and Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. W. LUCIER
Laboratory of Organ Function and Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

This study investigates binding characteristics of three derivatives of the estrogenic mycotoxin zearalenone by components of liver cytosol. Studies show that cytosol from male and female rats contain similar amounts of specific estrogen receptors which sediment in the 8-9 S region of 5-20% sucrose gradients. In addition, male liver cytosol contains a second class of "nonreceptor" estrogen-binding sites sedimenting in the 4-5 S region of sucrose gradients. Sedimentation analyses show that each of the mycotoxin derivatives (P-1496, P-1502, and P-1560) behave in an analogous manner to the synthetic estrogen, diethylstilbestrol, in that they compete effectively for 8 S receptor sites, whereas they bind poorly to 4 S nonreceptor sites. The binding affinities of the derivatives for receptor sites were determined from competition studies at 4° by using partially purified receptors and a range of concentrations of the competing ligands. During a short (90-min) incubation period, the relative binding affinities of P-1496, P-1502, and P-1560 for receptor sites were 30, 17, and 12%, respectively, of that exhibited by 17β-estradiol. The relative binding affinity of 17β-estradiol and P-1496 did not change as a function of time at 4°. However, the relative binding affinities of P-1502 and P-1560 decreased to 6.8 and 4.2%, respectively, during an extended incubation period at 4°. The binding affinity of each derivative was similar towards partially purified liver and uterine receptors during the extended incubation period. Dissociation rate constants of 17β-estradiol, P-1496, and P-1560 were obtained indirectly by measuring the rate of exchange of the unlabeled ligand with [3H]estradiol at 25°. The dissociation rate constants were 3.0 x 10-3 min-1, 5.6 x 10-3 min-1, and 0.14 min-1 for 17β-estradiol, P-1496, and P-1560, respectively. These studies show that the mycotoxin derivatives have the potential for modulating liver function through interaction with specific estrogen receptors. The true estrogen potential of the derivatives may depend upon the formation of a stable slowly dissociating ligand-receptor complex.

  • Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 20, Issue 1
1 Jul 1981
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Binding Properties of Zearalenone Mycotoxins to Hepatic Estrogen Receptors
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Binding Properties of Zearalenone Mycotoxins to Hepatic Estrogen Receptors

W. POWELL-JONES, S. RAEFORD and G. W. LUCIER
Molecular Pharmacology July 1, 1981, 20 (1) 35-42;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Binding Properties of Zearalenone Mycotoxins to Hepatic Estrogen Receptors

W. POWELL-JONES, S. RAEFORD and G. W. LUCIER
Molecular Pharmacology July 1, 1981, 20 (1) 35-42;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Michaelis Menten quantification of GPCR-G protein signalling
  • Human mAb 3F1 targeting the fuctional epitopes of Siglec-15
  • The regulation and mechanisms of ImKTX58 on KV1.3 channel
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics